Article ID Journal Published Year Pages File Type
2032255 Advances in Medical Sciences 2012 5 Pages PDF
Abstract
Our results indicate that HCV HVR-1 variability during the early phase of PEG-IFN-α and ribavirin therapy may be predictive of treatment outcome.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry, Genetics and Molecular Biology (General)
Preview
Variability of hepatitis C virus hypervariable region 1 (HVR-1) during the early phase of pegylated interferon and ribavirin therapy
Authors
, , , , , , , ,